BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, today announced the release of BioClinica WebSend, a system that simplifies and accelerates image collection for clinical studies. WebSend transfers and tracks medical images in real-time, offering key benefits over the standard manual transport methods commonly used in imaging trials, including faster delivery of image data, enhanced data quality with fewer site queries, and reduced cost.
“The launch of these enhanced products exemplifies that commitment.”
BioClinica WebSend is complemented by BioClinica WebView, the proven and established solution for managing the electronic sharing, blinding, tracking, archiving and analysis of medical images for clinical trials worldwide. Originally developed over 10 years ago by CardioNow, a business acquired by BioClinica from Agfa HealthCare in August 2009, BioClinica WebSend and WebView have evolved into a best-in-class solution for delivering true electronic clinical trial image management.
"BioClinica WebSend offers clients speed and flexibility that is simply not available with other image transport solutions. It allows any investigator site or imaging center globally to send all medical images to BioClinica electronically in a secure, regulatory-compliant manner. Along with BioClinica WebView, WebSend manages the collection and validation of those images," said Mark L. Weinstein, CEO of BioClinica, Inc.
"BioClinica WebSend and BioClinica WebView are further examples of how BioClinica continues to develop innovative solutions to help our customers better manage their clinical studies and achieve the best possible results. We remain committed to driving the advancement of image management for clinical trials with a blend of new technologies and services," said David Pitler, President of BioClinica's Bioimaging Services Division. "The launch of these enhanced products exemplifies that commitment."
Mirada Medical, BioClinica partner to extend oncology clinical trials